Wyckoff Heights Medical Center

Wyckoff Heights Medical Center was paid $117.81M by Medicaid between Jan 2018 and Dec 2024, across 611 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.

33Billing provider infoWYCKOFF HEIGHTS MEDICAL CENTER
BROOKLYN, NY 11237

33aNPI1700886322assigned 07/26/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$117.81M

24GClaims1,984,444

24DCodes billed611

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#12 of 231

Median peer was paid$561K

This provider vs. median210×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	20,784	$1.22M
2019	136,251	$6.09M
2020	287,516	$12.85M
2021	423,113	$20.12M
2022	408,141	$35.19M
2023	403,186	$26.24M
2024incomplete	305,453	$16.10M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	18%	145,223	116,985	$20.87M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	12%	68,833	64,187	$14.30M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.8%	47,903	45,853	$10.39M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	4.4%	43,006	38,205	$5.18M
99281	Emergency department visit for the evaluation and management, self-limited or minor	4.1%	22,372	21,628	$4.88M
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	3.7%	24,849	23,717	$4.34M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	3.2%	25,507	23,809	$3.76M
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	3.0%	23,276	22,190	$3.52M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.8%	14,988	14,630	$3.27M
80053	Comprehensive metabolic panel	2.4%	84,652	75,809	$2.77M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.2%	60,590	57,450	$2.57M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.5%	1,905	1,896	$1.73M

599 more codes

99204	Doctor's office visit, new patient (more involved)	1.4%	9,557	$1.64M
70450	Computed tomography, head or brain; without contrast material	1.2%	7,410	$1.43M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	1.2%	6,534	$1.36M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	8,928	$1.10M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	5,516	$1.04M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	983	$954K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	7,820	$935K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	13,303	$910K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	24,193	$888K
86850		<1%	13,717	$853K
A0427	Emergency ambulance ride, advanced life support	<1%	3,993	$824K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	4,477	$762K
99285	Emergency room visit (most serious)	<1%	3,855	$760K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	611	$648K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,407	$639K
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	3,675	$628K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	10,866	$620K
36415	Collection of venous blood by venipuncture	<1%	21,125	$576K
76818		<1%	7,293	$551K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	6,071	$543K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	3,875	$531K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	4,355	$525K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,944	$501K
92551		<1%	4,486	$460K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	3,394	$457K
90832	Psychotherapy session, about 30 minutes	<1%	3,453	$443K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	13,804	$441K
97162		<1%	3,028	$403K
86480		<1%	6,298	$375K
97010		<1%	10,281	$345K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	2,667	$328K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,787	$326K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	961	$314K
80048	Basic metabolic panel (calcium, ionized)	<1%	11,298	$297K
1159F		<1%	17,486	$297K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	2,279	$293K
1126F		<1%	13,411	$291K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	2,410	$289K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	2,098	$284K
93970		<1%	1,775	$277K
76770		<1%	1,384	$276K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	1,783	$267K
12001		<1%	818	$262K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	5,612	$248K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	3,363	$248K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,879	$240K
80061	Lipid panel	<1%	27,586	$240K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	15,536	$235K
99381		<1%	1,594	$234K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	1,825	$225K
99215	Doctor's office visit, returning patient (complex)	<1%	1,338	$222K
76000		<1%	698	$216K
86901		<1%	13,841	$212K
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	<1%	1,065	$212K
12011		<1%	611	$210K
86710		<1%	26,813	$206K
87623		<1%	4,177	$186K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	9,681	$185K
76830	Ultrasound, transvaginal	<1%	3,971	$183K
76801		<1%	2,235	$181K
82948		<1%	31,782	$178K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,087	$177K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,671	$177K
29580		<1%	822	$176K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	6,422	$172K
76641		<1%	2,574	$167K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,517	$166K
87536		<1%	2,778	$164K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	14,662	$163K
86900		<1%	13,849	$159K
84703		<1%	33,031	$156K
A0425	Ground mileage, per statute mile	<1%	29,164	$154K
77066	Tomosynthesis, mammo	<1%	1,433	$150K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,845	$148K
90461		<1%	7,317	$147K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	81,860	$143K
88142		<1%	5,771	$143K
99205	Prolong outpt/office vis	<1%	756	$142K
J1756	Injection, iron sucrose, 1 mg	<1%	3,137	$140K
1125F		<1%	4,993	$127K
90670		<1%	5,279	$122K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	690	$121K
77063	Screening digital breast tomosynthesis, bilateral	<1%	5,548	$113K
90649		<1%	1,975	$112K
86360		<1%	2,813	$107K
T1013	Sign language or oral interpretive services, per 15 minutes	<1%	2,504	$105K
83655		<1%	8,449	$100K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,040	$94K
29125		<1%	538	$93K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	266	$93K
0002A		<1%	3,501	$91K
83036	Hemoglobin; glycosylated (A1C)	<1%	26,140	$90K
99385		<1%	729	$90K
0001A		<1%	3,966	$90K
76536		<1%	1,450	$89K
83970		<1%	2,619	$88K
71046	Radiologic examination, chest; 2 views	<1%	17,709	$88K
70486		<1%	1,355	$86K
84443	Thyroid stimulating hormone (TSH)	<1%	24,607	$84K
96161		<1%	1,607	$84K
10060		<1%	288	$83K
11721		<1%	1,315	$82K
90686		<1%	4,657	$82K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	414	$80K
86708		<1%	7,683	$73K
96361	Intravenous infusion, hydration; each additional hour	<1%	394	$70K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,944	$68K
71250		<1%	770	$67K
81025		<1%	1,218	$67K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,824	$67K
84439		<1%	14,615	$66K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	1,176	$65K
97014		<1%	4,687	$64K
41899	Unlisted procedure, dentoalveolar structures	<1%	54	$64K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	375	$59K
77065	Tomosynthesis, mammo	<1%	776	$59K
80074		<1%	2,502	$55K
86780		<1%	12,815	$55K
76813		<1%	798	$55K
81001		<1%	45,672	$54K
73630		<1%	4,968	$53K
86706		<1%	10,564	$53K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	222	$53K
82803		<1%	841	$51K
85610		<1%	17,680	$51K
96160		<1%	1,045	$51K
76642		<1%	1,220	$51K
86803		<1%	9,710	$50K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	6,362	$49K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	492	$48K
87631		<1%	1,267	$48K
84702		<1%	10,048	$45K
58558		<1%	39	$45K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,227	$43K
94060		<1%	1,369	$43K
87086	Culture, bacterial; quantitative colony count, urine	<1%	12,279	$43K
82607		<1%	5,116	$42K
74240		<1%	539	$41K
72131		<1%	336	$41K
74160		<1%	226	$41K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,661	$40K
90647		<1%	3,958	$40K
90651		<1%	567	$40K
90715		<1%	1,910	$39K
97016		<1%	629	$38K
81002		<1%	1,413	$38K
99386		<1%	336	$38K
86704		<1%	7,835	$38K
82652		<1%	2,015	$37K
90714		<1%	2,434	$37K
29515		<1%	195	$36K
77080		<1%	1,078	$35K
83880		<1%	1,815	$34K
83013		<1%	696	$33K
94729		<1%	1,540	$33K
31575		<1%	260	$33K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	149	$32K
90633		<1%	2,893	$31K
82728		<1%	4,472	$31K
73562		<1%	2,839	$31K
12002		<1%	77	$31K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	218	$31K
0004A		<1%	961	$30K
85730		<1%	15,804	$30K
92557		<1%	553	$30K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	1,043	$29K
99173		<1%	3,160	$28K
92567		<1%	856	$28K
A4649	Surgical supply; miscellaneous	<1%	5,659	$28K
77062		<1%	641	$28K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	251	$28K
1003F		<1%	1,556	$28K
76870		<1%	484	$28K
93971		<1%	382	$28K
73610		<1%	3,178	$27K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,049	$27K
88304		<1%	1,222	$27K
82746		<1%	3,915	$27K
86769		<1%	1,097	$26K
90677		<1%	984	$26K
92250		<1%	492	$26K
92201		<1%	517	$25K
72100		<1%	2,138	$25K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	289	$25K
90681		<1%	3,123	$24K
80076		<1%	2,288	$24K
94727		<1%	1,026	$24K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	336	$24K
90716		<1%	1,469	$23K
73030		<1%	2,772	$23K
90723		<1%	2,990	$23K
1005F		<1%	366	$23K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	2,627	$22K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	4,337	$22K
97597		<1%	68	$22K
90750		<1%	141	$21K
87480		<1%	2,442	$21K
71275	Computed tomographic angiography, chest, with contrast material	<1%	115	$20K
90734		<1%	1,219	$20K
73110		<1%	2,026	$20K
86762		<1%	2,391	$19K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,251	$18K
87807		<1%	23,613	$18K
11043		<1%	54	$18K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	153	$18K
93454		<1%	12	$18K
88312		<1%	1,587	$18K
99243		<1%	168	$18K
84481		<1%	4,709	$18K
82043		<1%	5,280	$17K
36600		<1%	911	$16K
99442		<1%	417	$16K
87660		<1%	2,432	$16K
87510		<1%	2,420	$16K
90707		<1%	1,498	$15K
90739		<1%	199	$15K
73130		<1%	2,626	$15K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	214	$15K
88720		<1%	250	$15K
87340		<1%	5,327	$14K
90694		<1%	301	$14K
84153		<1%	1,804	$14K
90620		<1%	610	$14K
86609		<1%	1,478	$14K
74150		<1%	85	$14K
97161		<1%	135	$14K
99404		<1%	162	$14K
90657		<1%	6,407	$13K
83001		<1%	1,109	$13K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	560	$13K
86787		<1%	2,607	$13K
90698		<1%	1,492	$13K
G0378	Hospital observation service, per hour	<1%	27	$13K
90791	Psychiatric diagnostic evaluation	<1%	69	$13K
88160		<1%	254	$13K
84402		<1%	700	$12K
84146		<1%	931	$12K
97164		<1%	176	$12K
84144		<1%	505	$12K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	43	$12K
97022		<1%	246	$12K
76827		<1%	297	$12K
82105		<1%	1,188	$12K
29540		<1%	67	$12K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	954	$12K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	48	$12K
80305		<1%	4,077	$11K
71045	Radiologic examination, chest; single view	<1%	6,622	$11K
90792	Psychiatric diagnostic evaluation with medical services	<1%	76	$11K
72110		<1%	649	$11K
99201		<1%	110	$11K
69210		<1%	175	$10K
99496		<1%	94	$10K
A7003	Administration set, with small volume nonfiltered pneumatic nebulizer, disposable	<1%	1,031	$10K
72050		<1%	590	$10K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	275	$10K
J3490	Unclassified drugs	<1%	817	$10K
99401		<1%	336	$10K
87070		<1%	1,909	$10K
70491		<1%	54	$9K
90710		<1%	951	$9K
92083		<1%	174	$9K
96367		<1%	181	$9K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	2,004	$9K
82950		<1%	1,485	$9K
96375	Therapeutic injection; each additional sequential IV push	<1%	2,256	$9K
86141		<1%	2,166	$8K
90685		<1%	411	$8K
90700		<1%	1,336	$8K
83020		<1%	1,271	$8K
83550		<1%	3,237	$8K
76819	Fetal biophysical profile; without non-stress testing	<1%	137	$8K
64483		<1%	13	$8K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	401	$8K
90696		<1%	811	$8K
73502		<1%	839	$8K
94726		<1%	294	$8K
96127		<1%	2,805	$8K
94375		<1%	372	$8K
S0028	Injection, famotidine, 20 mg	<1%	1,281	$8K
86709		<1%	1,736	$7K
31231		<1%	52	$7K
86696		<1%	1,070	$7K
76881		<1%	139	$7K
88313		<1%	1,613	$7K
99241		<1%	78	$7K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	26	$7K
86765		<1%	853	$7K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	277	$7K
99443		<1%	124	$6K
74019		<1%	1,815	$6K
73564		<1%	705	$6K
90656		<1%	1,840	$6K
86702		<1%	87	$6K
73080		<1%	848	$6K
4040F		<1%	93	$6K
90472	Immunization administration, each additional vaccine (list separately)	<1%	864	$6K
20610		<1%	28	$6K
86694		<1%	873	$6K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	14	$6K
29130		<1%	37	$6K
73560		<1%	375	$6K
87522	Neg quan hep c or qual rna	<1%	170	$6K
0072A		<1%	140	$6K
92588		<1%	72	$6K
73090		<1%	864	$6K
73590		<1%	1,043	$6K
86376		<1%	504	$5K
97018		<1%	59	$5K
96368		<1%	137	$5K
92226		<1%	99	$5K
94010		<1%	545	$5K
86695		<1%	857	$5K
36591		<1%	180	$5K
G0008	Administration of influenza virus vaccine	<1%	515	$5K
0124A		<1%	129	$5K
83735		<1%	3,889	$5K
82248		<1%	1,231	$5K
90697		<1%	459	$5K
93925		<1%	51	$5K
99242		<1%	87	$5K
86800		<1%	437	$4K
86735		<1%	858	$4K
0003A		<1%	136	$4K
92202		<1%	141	$4K
92134		<1%	90	$4K
29581		<1%	36	$4K
70496		<1%	24	$4K
J2704	Injection, propofol, 10 mg	<1%	4,787	$4K
87081		<1%	1,492	$4K
86038		<1%	963	$4K
85379		<1%	1,035	$4K
88162		<1%	84	$4K
Q3014	Telehealth originating site facility fee	<1%	145	$4K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	4,080	$4K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	4,332	$4K
82677		<1%	559	$4K
68761		<1%	62	$4K
83525		<1%	401	$3K
92015	Determination of refractive state	<1%	301	$3K
20550		<1%	14	$3K
87186		<1%	2,011	$3K
82274		<1%	564	$3K
72141		<1%	16	$3K
0064A		<1%	98	$3K
0071A		<1%	80	$3K
99219		<1%	53	$3K
1111F		<1%	376	$3K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	780	$3K
3008F		<1%	2,151	$3K
84100		<1%	3,261	$3K
94664		<1%	226	$3K
91320		<1%	60	$3K
C1769	Guide wire	<1%	191	$3K
90662		<1%	134	$3K
84425		<1%	326	$3K
72193		<1%	184	$3K
85651		<1%	2,775	$3K
72081		<1%	136	$3K
74246		<1%	24	$3K
1036F		<1%	418	$3K
84156		<1%	1,292	$3K
94760		<1%	1,404	$3K
87800		<1%	199	$3K
99406		<1%	68	$2K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	134	$2K
92225		<1%	37	$2K
82627		<1%	178	$2K
92133		<1%	63	$2K
90746		<1%	55	$2K
82270		<1%	665	$2K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	27	$2K
90671		<1%	149	$2K
1160F		<1%	14,661	$2K
87205		<1%	2,240	$2K
84484		<1%	7,556	$2K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	68	$2K
71270		<1%	12	$2K
84590		<1%	269	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	5,153	$2K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	474	$2K
84480		<1%	429	$2K
83690		<1%	8,756	$2K
84550		<1%	805	$2K
87350		<1%	351	$2K
59430		<1%	12	$2K
94200		<1%	343	$2K
73620		<1%	281	$2K
84436		<1%	566	$2K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,007	$2K
73521		<1%	129	$2K
94150		<1%	474	$2K
11730		<1%	19	$2K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	17,554	$2K
1000F		<1%	575	$2K
71271		<1%	55	$2K
99495		<1%	25	$2K
86617		<1%	137	$1K
86336		<1%	588	$1K
92553		<1%	14	$1K
87338		<1%	183	$1K
2022F		<1%	227	$1K
0031A		<1%	58	$1K
73140		<1%	247	$1K
90675		<1%	29	$1K
84446		<1%	171	$1K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	557	$1K
93923		<1%	25	$1K
J7030	Infusion, normal saline solution , 1000 cc	<1%	5,301	$1K
86592		<1%	887	$1K
99441		<1%	61	$1K
86403		<1%	406	$1K
73120		<1%	112	$1K
74241		<1%	13	$1K
1220F		<1%	1,038	$1K
92579		<1%	24	$1K
82550		<1%	764	$1K
86705		<1%	328	$1K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	6,705	$1K
88307		<1%	28	$1K
83615		<1%	668	$1K
90732		<1%	146	$999.52
83498		<1%	56	$992.82
J7050	Infusion, normal saline solution, 250 cc	<1%	387	$973.38
90480		<1%	36	$970.12
80329		<1%	401	$940.73
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	108	$928.46
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	4,603	$920.69
73600		<1%	28	$905.79
Q2039	Influenza virus vaccine, not otherwise specified	<1%	91	$904.79
72072		<1%	92	$885.32
87328		<1%	59	$884.09
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	8,886	$870.48
80050	General health panel	<1%	41	$868.04
84466		<1%	157	$859.19
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	26	$836.78
97803		<1%	30	$828.31
90674		<1%	43	$824.46
88300		<1%	279	$795.70
83540		<1%	333	$758.89
J1170	Injection, hydromorphone, up to 4 mg	<1%	2,148	$752.73
0012A		<1%	63	$739.98
73100		<1%	74	$737.81
81003		<1%	770	$731.83
87040		<1%	2,542	$697.86
0011A		<1%	39	$678.47
90473		<1%	246	$644.27
84235		<1%	17	$629.81
87329		<1%	58	$628.46
87045		<1%	89	$622.20
82465		<1%	348	$616.47
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,321	$604.76
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,338	$603.25
0054A		<1%	16	$603.02
36410		<1%	30	$601.74
87209		<1%	74	$592.50
3017F		<1%	101	$579.29
0502F		<1%	87	$579.26
87184		<1%	295	$575.27
84207		<1%	27	$570.73
71101		<1%	66	$561.14
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	1,088	$550.04
83002		<1%	46	$524.42
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,975	$518.56
97802		<1%	12	$514.65
72192		<1%	67	$492.85
82670		<1%	28	$472.18
77061		<1%	13	$471.43
82180		<1%	113	$455.12
84403		<1%	26	$438.77
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,515	$434.91
82784		<1%	88	$433.87
86593		<1%	372	$429.00
93017		<1%	12	$424.38
90660		<1%	18	$391.98
70498		<1%	14	$390.54
86320		<1%	15	$379.65
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,052	$374.05
84134		<1%	64	$360.91
84154		<1%	29	$356.60
82150		<1%	449	$341.66
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,491	$339.13
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	331	$333.81
83605		<1%	1,201	$333.09
80320		<1%	1,685	$321.82
74018		<1%	70	$320.39
4035F		<1%	247	$300.96
86580		<1%	40	$295.09
82525		<1%	37	$274.54
82951		<1%	42	$271.33
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	265	$269.59
90653		<1%	35	$242.60
82533		<1%	26	$240.45
87430		<1%	254	$231.61
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	211	$226.92
J7510	Prednisolone oral, per 5 mg	<1%	276	$225.83
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	1,071	$218.47
91312		<1%	103	$212.43
J1644	Injection, heparin sodium, per 1000 units	<1%	626	$201.98
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	126	$199.67
Q0247	Injection, sotrovimab, 500 mg	<1%	43	$198.99
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	52	$195.55
86225		<1%	69	$193.79
84630		<1%	39	$193.16
88311		<1%	66	$192.45
86160		<1%	28	$190.45
85044		<1%	220	$190.35
92552		<1%	19	$178.58
3046F		<1%	309	$177.00
1170F		<1%	694	$177.00
1006F		<1%	107	$177.00
71048		<1%	14	$176.58
90381		<1%	15	$175.77
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	5,959	$172.20
72040		<1%	28	$164.16
86430		<1%	57	$160.43
72070		<1%	12	$159.72
73552		<1%	25	$143.25
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	38	$130.00
73060		<1%	15	$124.60
85660		<1%	49	$124.32
J3475	Injection, magnesium sulfate, per 500 mg	<1%	325	$122.41
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	338	$122.35
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,239	$114.50
83519		<1%	12	$99.12
88302		<1%	71	$89.64
82552		<1%	65	$81.06
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	40	$78.53
J1815	Injection, insulin, per 5 units	<1%	47	$78.30
93000		<1%	57	$76.20
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	126	$67.91
87210		<1%	34	$66.62
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,279	$59.80
J2060	Injection, lorazepam, 2 mg	<1%	629	$59.40
83516		<1%	17	$58.79
J1741	Injection, ibuprofen, 100 mg	<1%	14	$57.69
84132		<1%	324	$53.99
J1953	Injection, levetiracetam, 10 mg	<1%	31	$49.00
85384		<1%	40	$48.30
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	27	$47.60
90658		<1%	119	$46.28
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	198	$40.69
73070		<1%	12	$39.86
J3370	Injection, vancomycin hcl, 500 mg	<1%	48	$37.89
J1630	Injection, haloperidol, up to 5 mg	<1%	181	$24.85
S0077	Injection, clindamycin phosphate, 300 mg	<1%	13	$20.68
A6223	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing	<1%	97	$15.51
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	27	$13.82
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	27	$12.58
70360		<1%	39	$12.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	12	$11.06
J0780	Injection, prochlorperazine, up to 10 mg	<1%	13	$10.36
A4606	Oxygen probe for use with oximeter device, replacement	<1%	137	$10.00
J0736	Injection, clindamycin phosphate, 300 mg	<1%	15	$9.60
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	41	$6.50
91300		<1%	6,793	$6.24
82009		<1%	41	$6.11
J1836	Injection, metronidazole, 10 mg	<1%	12	$3.00
J1171	Injection, hydromorphone, 0.1 mg	<1%	17	$1.80
91307		<1%	90	$0.66
91305		<1%	17	$0.15
91301		<1%	118	$0.14
Q0243	Injection, casirivimab and imdevimab, 2400 mg	<1%	35	$0.09
91306		<1%	44	$0.07
3079F		<1%	755	$0.06
3074F		<1%	1,293	$0.05
3075F		<1%	485	$0.05
3078F		<1%	1,431	$0.04
3051F		<1%	99	$0.02
4004F		0%	130	$0.00
G8482	Influenza immunization administered or previously received	0%	5,683	$0.00
3288F		0%	429	$0.00
3077F		0%	381	$0.00
3016F		0%	66	$0.00
99499		0%	38	$0.00
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	10,452	$0.00
3023F		0%	253	$0.00
A4550	Surgical trays	0%	76	$0.00
73000		0%	12	$0.00
3045F		0%	31	$0.00
A4246	Betadine or phisohex solution, per pint	0%	12	$0.00
99080		0%	42	$0.00
S1015	Iv tubing extension set	0%	27	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	18	$0.00
A4320	Irrigation tray with bulb or piston syringe, any purpose	0%	36	$0.00
3048F		0%	244	$0.00
2015F		0%	279	$0.00
3080F		0%	42	$0.00
3044F		0%	822	$0.00
3052F		0%	16	$0.00
A4461	Surgical dressing holder, non-reusable, each	0%	274	$0.00
99429		0%	776	$0.00
99024		0%	15	$0.00
2016F		0%	318	$0.00
4037F		0%	457	$0.00
3049F		0%	128	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	98	$0.00
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	0%	12	$0.00
91303		0%	42	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVUTRANO, FRANK (C.F.O.)